TNF and juvenile idiopathic arthritis: Similarly, Tynjälä et al. reported that children with JIA treated with either etanercept or infliximab exhibited an increased growth velocity by +0.45 cm during anti-TNF therapy with a growth rate increasing by +1.8 cm/year [94].